A new Withings scale can now check 60+ health signals

Signals Inbox·July 21, 2026·Consumer Health

Withings is turning the bathroom scale into a $599.95 home health station. BodyScan 2 now measures more than 60 biomarkers in 90 seconds, up from 40+ on the previous Body Scan, while adding heart-pumping analysis and hypertension alerts that used to require separate devices or clinical checks.

Q1What actually launched?

Withings has started selling BodyScan 2 in the United States for $599.95. The official product page says it can run a 90-second scan covering more than 60 biomarkers, including body composition, heart activity, vascular health, nerve response, cellular health, and metabolic signals.

Q2What is new versus the old model?

The previous Body Scan measured more than 40 biomarkers. BodyScan 2 pushes that above 60 and adds heart-pumping performance, hypertension alerts, more detailed metabolic readings, and bioimpedance across 13 frequencies up to 800 kHz. This is a much bigger jump than a normal yearly scale update.

Q3Why does the 60+ number matter?

Most smart scales mainly estimate weight, fat, muscle, water, BMI, and a few related metrics. BodyScan 2 is trying to combine several home-health devices into one daily check. The pitch is not better weight tracking. It is spotting changes in heart, artery, nerve, and metabolic health before a person feels sick.

Q4Is this really medical-grade?

Some parts use technologies also found in medicine, including a six-lead ECG and impedance cardiography. Withings also says its fat-mass readings reached a 99% correlation with DEXA in internal testing. But the scale does not replace a doctor, a blood test, or a hospital scan. Its biggest value is repeated trend data at home.

Q5What is the real competitive shift?

The smart-scale fight is moving beyond body fat percentages. Cheap models can already track basic composition for under $100, so Withings is moving upmarket into preventive health. At $599.95, it costs far more than a normal scale, but much less than buying repeated clinical tests. The bet is that people will pay for a daily early-warning system.

Q6So should I care?

Yes, because this is another step toward the bathroom becoming a health-monitoring hub. The hard question is whether all 60+ readings are accurate, useful, and clear enough to change behavior. If they are, scales could become continuous screening tools. If not, this is an expensive dashboard full of numbers people cannot act on.